XML 38 R31.htm IDEA: XBRL DOCUMENT v3.25.1
Stock Option and Grant Plan (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Summary of Stock-based Compensation Expense

Stock-based compensation expense recorded as research and development and general and administrative expenses in the condensed consolidated statements of operations and other comprehensive loss is as follows (in thousands):

 

 

Three Months Ended
March 31,

 

 

 

2025

 

 

2024

 

Research and development

 

$

15,733

 

 

$

17,645

 

General and administrative

 

 

10,949

 

 

 

11,636

 

Total stock-based compensation expense

 

$

26,682

 

 

$

29,281

 

Summary of Stock Option Activity Under Equity Award Plans

The following table provides a summary of stock option activity under the Company’s equity award plans:

 

 

Number
of options

 

 

Weighted
average
exercise
price

 

Outstanding at December 31, 2024

 

 

9,605,542

 

 

$

38.62

 

Granted

 

 

2,155,500

 

 

 

25.87

 

Exercised

 

 

(74,707

)

 

 

9.63

 

Forfeited

 

 

(60,259

)

 

 

47.04

 

Outstanding at March 31, 2025

 

 

11,626,076

 

 

 

36.40

 

Exercisable as of March 31, 2025

 

 

6,295,927

 

 

$

41.33

 

Summary of Restricted Stock Activity

The following table summarizes the Company’s restricted stock activity:

 

 

Shares

 

 

Weighted-
average grant
date fair
value

 

Unvested as of December 31, 2024

 

 

2,576,855

 

 

$

36.98

 

Issued

 

 

1,129,850

 

 

 

19.53

 

Vested

 

 

(607,196

)

 

 

44.12

 

Forfeited

 

 

(28,625

)

 

 

39.61

 

Unvested as of March 31, 2025

 

 

3,070,884

 

 

$

29.13